2021 Q4 Form 10-Q Financial Statement

#000147793222000262 Filed on January 14, 2022

View on sec.gov

Income Statement

Concept 2021 Q4 2020 Q4

Balance Sheet

Concept 2021 Q4 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $34.85K $80.91K
YoY Change -56.93% 75.05%
Cash & Equivalents $34.85K
Short-Term Investments
Other Short-Term Assets $10.00K $155.4K
YoY Change -93.56% 3007.6%
Inventory $176.0K $291.9K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $220.8K $528.2K
YoY Change -58.2% 47.68%
LONG-TERM ASSETS
Property, Plant & Equipment $5.495M $4.914M
YoY Change 11.81% 3.55%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $5.520M $4.914M
YoY Change 12.32% 3.55%
TOTAL ASSETS
Total Short-Term Assets $220.8K $528.2K
Total Long-Term Assets $5.520M $4.914M
Total Assets $5.741M $5.443M
YoY Change 5.48% 6.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $648.6K $333.3K
YoY Change 94.6% 182.88%
Accrued Expenses $64.94K $40.78K
YoY Change 59.24% 57.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $3.562M $514.5K
YoY Change 592.29%
Total Short-Term Liabilities $8.549M $5.373M
YoY Change 59.11% 167.92%
LONG-TERM LIABILITIES
Long-Term Debt $4.560M $4.607M
YoY Change -1.02% -1.84%
Other Long-Term Liabilities $0.00
YoY Change
Total Long-Term Liabilities $4.560M $4.607M
YoY Change -1.02% -1.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.549M $5.373M
Total Long-Term Liabilities $4.560M $4.607M
Total Liabilities $13.11M $9.980M
YoY Change 31.35% 48.99%
SHAREHOLDERS EQUITY
Retained Earnings -$59.49M
YoY Change
Common Stock $44.48K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.368M -$4.537M
YoY Change
Total Liabilities & Shareholders Equity $5.741M $5.443M
YoY Change 5.48% 6.64%

Cashflow Statement

Concept 2021 Q4 2020 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 dei Document Type
DocumentType
10-Q
CY2021Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q4 dei Document Period End Date
DocumentPeriodEndDate
2021-10-31
CY2021Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q4 dei Entity File Number
EntityFileNumber
000-54338
CY2021Q4 dei Entity Registrant Name
EntityRegistrantName
GREEN HYGIENICS HOLDINGS INC.
CY2021Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
CY2021Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2801338
CY2021Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
13795 Blaisdell Place
CY2021Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 202
CY2021Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
Poway
CY2021Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92064
CY2021Q4 dei City Area Code
CityAreaCode
1-855
CY2021Q4 dei Local Phone Number
LocalPhoneNumber
802-0299
CY2021Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44482138 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34847 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
507512 USD
CY2021Q4 us-gaap Deposits Assets
DepositsAssets
10000 USD
CY2021Q3 us-gaap Deposits Assets
DepositsAssets
0 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
175957 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
0 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
220804 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
507512 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5494912 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5522326 USD
CY2021Q4 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
25000 USD
CY2021Q3 us-gaap Intangible Assets Current
IntangibleAssetsCurrent
25000 USD
CY2021Q4 us-gaap Assets
Assets
5740716 USD
CY2021Q3 us-gaap Assets
Assets
6054838 USD
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
396160 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
749592 USD
CY2021Q4 us-gaap Servicing Liability
ServicingLiability
403503 USD
CY2021Q3 us-gaap Servicing Liability
ServicingLiability
304383 USD
CY2021Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
648638 USD
CY2021Q3 gryn Mortgage Payable
MortgagePayable
2750000 USD
CY2021Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1760000 USD
CY2021Q3 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
1760000 USD
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4559694 USD
CY2021Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
523791 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4575591 USD
CY2021Q4 us-gaap Interest Payable Current
InterestPayableCurrent
64937 USD
CY2021Q4 us-gaap Liabilities
Liabilities
13108690 USD
CY2021Q3 us-gaap Liabilities
Liabilities
12898367 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000 shares
CY2021Q3 us-gaap Interest Payable Current
InterestPayableCurrent
58953 USD
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3562038 USD
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44482138 shares
CY2021Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
3557594 USD
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44126138 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
44482 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
44126 USD
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3473720 USD
CY2021Q4 gryn Stock Payable
StockPayable
100000 USD
CY2020Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40956924 shares
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-6843529 USD
CY2021Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
3128463 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
8548996 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
8322776 USD
CY2021Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
49694 USD
CY2021Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
65891 USD
CY2021Q4 gryn Mortgage Payable
MortgagePayable
2750000 USD
CY2021Q3 gryn Stock Payable
StockPayable
812000 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51977994 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
51186075 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59490450 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58885730 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-7367974 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-6843529 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5740716 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6054838 USD
CY2021Q4 us-gaap Revenues
Revenues
4500 USD
CY2020Q4 us-gaap Revenues
Revenues
40954 USD
CY2021Q4 us-gaap Business Development
BusinessDevelopment
154655 USD
CY2020Q4 us-gaap Business Development
BusinessDevelopment
85991 USD
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1904950 USD
CY2021Q4 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
157500 USD
CY2020Q4 us-gaap Other Labor Related Expenses
OtherLaborRelatedExpenses
52500 USD
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
179828 USD
CY2020Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
231048 USD
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
491983 USD
CY2020Q4 us-gaap Operating Expenses
OperatingExpenses
2279235 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-487483 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-2238281 USD
CY2021Q4 us-gaap Interest Expense
InterestExpense
297237 USD
CY2020Q4 us-gaap Interest Expense
InterestExpense
191440 USD
CY2021Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
180000 USD
CY2020Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2021Q4 gryn Other Income And Expenses
OtherIncomeAndExpenses
-117237 USD
CY2020Q4 gryn Other Income And Expenses
OtherIncomeAndExpenses
-191440 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-604720 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-2429721 USD
CY2021Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2021Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44482138 shares
CY2020Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1904050 USD
CY2021Q4 gryn Imputed Interest
ImputedInterest
80275 USD
CY2021Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-604720 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-7367974 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
-4432520 USD
CY2020Q4 gryn Imputed Interest
ImputedInterest
76778 USD
CY2020Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1904050 USD
CY2020Q4 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
155383 USD
CY2020Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
188700 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-2429721 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-4537330 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-604720 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
-2429721 USD
CY2021Q4 gryn Imputed Interest
ImputedInterest
80275 USD
CY2020Q4 gryn Imputed Interest
ImputedInterest
76778 USD
CY2021Q4 us-gaap Depreciation
Depreciation
62439 USD
CY2020Q4 us-gaap Depreciation
Depreciation
30177 USD
CY2021Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
0 USD
CY2021Q4 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2020Q4 us-gaap Paid In Kind Interest
PaidInKindInterest
716 USD
CY2021Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1500 USD
CY2021Q4 gryn Foreign Currency Losses
ForeignCurrencyLosses
1321 USD
CY2020Q4 gryn Foreign Currency Losses
ForeignCurrencyLosses
0 USD
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
4444 USD
CY2020Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 USD
CY2021Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-10000 USD
CY2020Q4 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
0 USD
CY2021Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-175957 USD
CY2020Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-291928 USD
CY2021Q4 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
5984 USD
CY2020Q4 us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
-117639 USD
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-254312 USD
CY2020Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
119609 USD
CY2021Q4 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
124847 USD
CY2020Q4 us-gaap Increase Decrease In Notes Receivable Related Parties
IncreaseDecreaseInNotesReceivableRelatedParties
27500 USD
CY2021Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2020Q4 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-15973 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-765679 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-694931 USD
CY2021Q4 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
35025 USD
CY2020Q4 us-gaap Payments For Purchase Of Other Assets1
PaymentsForPurchaseOfOtherAssets1
29833 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-35025 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-29833 USD
CY2021Q4 gryn Shares Issued For Prepaid Expenses
SharesIssuedForPrepaidExpenses
0 USD
CY2020Q4 gryn Payments On Discounted Note Payable
PaymentsOnDiscountedNotePayable
171213 USD
CY2021Q4 gryn Payments On Related Parties Loans
PaymentsOnRelatedPartiesLoans
77913 USD
CY2020Q4 gryn Payments On Related Parties Loans
PaymentsOnRelatedPartiesLoans
70000 USD
CY2021Q4 gryn Principle Payments On Notes Payable
PrinciplePaymentsOnNotesPayable
15897 USD
CY2020Q4 gryn Principle Payments On Notes Payable
PrinciplePaymentsOnNotesPayable
7149 USD
CY2021Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
421849 USD
CY2020Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1013500 USD
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328039 USD
CY2020Q4 gryn Shares Issued For Vehicles
SharesIssuedForVehicles
188700 USD
CY2020Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
765138 USD
CY2021Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-472665 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
40374 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
507512 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
40538 USD
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
34847 USD
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
80912 USD
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
207328 USD
CY2020Q4 us-gaap Interest Paid Net
InterestPaidNet
230036 USD
CY2021Q4 gryn Shares Issued For Vehicles
SharesIssuedForVehicles
0 USD
CY2020Q4 gryn Shares Issued For Prepaid Expenses
SharesIssuedForPrepaidExpenses
155383 USD
CY2021Q4 gryn Shares Issued For Stock Payable
SharesIssuedForStockPayable
712000 USD
CY2020Q4 gryn Shares Issued For Stock Payable
SharesIssuedForStockPayable
92000 USD
CY2021Q4 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses in the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</p>
CY2021Q4 gryn Harvested Flower
harvestedFlower
30000 GBP
CY2021Q4 gryn Biomass
Biomass
40000 GBP
CY2020Q4 gryn Cost And Expenses
CostAndExpenses
175956 USD
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44482138 shares
CY2020Q3 us-gaap Deferred Revenue
DeferredRevenue
15973 USD
CY2021 gryn Production Equipments
ProductionEquipments
854899 USD
CY2021Q4 gryn Production Equipments
ProductionEquipments
836785 USD
CY2021 gryn Furniture And Office Equipment
FurnitureAndOfficeEquipment
4859 USD
CY2021Q4 gryn Furniture And Office Equipment
FurnitureAndOfficeEquipment
4451 USD
CY2021 gryn Payments To Acquire Building
PaymentsToAcquireBuilding
450206 USD
CY2021Q4 gryn Payments To Acquire Building
PaymentsToAcquireBuilding
442023 USD
CY2021 gryn Land And Buildings
LandAndBuildings
4212362 USD
CY2021Q4 gryn Land And Buildings
LandAndBuildings
4212362 USD
CY2021 gryn Purchase Of Fixed Assets
PurchaseOfFixedAssets
5522326 USD
CY2021Q4 gryn Purchase Of Fixed Assets
PurchaseOfFixedAssets
5494912 USD
CY2021Q4 us-gaap Depreciation
Depreciation
62439 USD
CY2020Q4 us-gaap Depreciation
Depreciation
30177 USD
CY2021Q4 us-gaap Interest Expense Other
InterestExpenseOther
100078 USD
CY2021Q1 us-gaap Notes Issued1
NotesIssued1
406137 USD
CY2021Q1 us-gaap Short Term Debt Percentage Bearing Fixed Interest Rate
ShortTermDebtPercentageBearingFixedInterestRate
0.0475 pure
CY2021Q4 gryn Promissory Note Interest Expense
PromissoryNoteInterestExpense
4863 USD
CY2020Q3 gryn Principal Amount
PrincipalAmount
200000 USD
CY2021Q4 gryn Imputed Interestandloans
ImputedInterestandloans
80275 USD
CY2020Q4 gryn Imputed Interestandloans
ImputedInterestandloans
76778 USD
CY2021Q4 us-gaap Management Fee Expense
ManagementFeeExpense
180097 USD
CY2020Q4 us-gaap Management Fee Expense
ManagementFeeExpense
52500 USD
CY2021Q4 gryn Payment Of Related Party Expenses Beginning
PaymentOfRelatedPartyExpensesBeginning
523791 USD
CY2021Q4 gryn Additions
Additions
180097 USD
CY2021Q4 gryn Payments
Payments
55250 USD
CY2021Q4 gryn Payment Of Related Party Expenses Ending
PaymentOfRelatedPartyExpensesEnding
648638 USD
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
375000000 shares
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021 us-gaap Dividends Share Based Compensation
DividendsShareBasedCompensation
355550 USD
CY2020Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
100000 shares
CY2021 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
50000 shares
CY2021 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
712000 USD
CY2021Q3 gryn Exercise Price Per Warranty
ExercisePricePerWarranty
3.00
CY2021 gryn Purchase Shares Of Common Stock
PurchaseSharesOfCommonStock
356000 shares
CY2021Q4 gryn Summary Of Warrent Activitytabletextblock
SummaryOfWarrentActivitytabletextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Number of </strong></p><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Warrants</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;text-align:center;margin:0px 0px 0px 0in"><strong>Weighted average exercise price</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Outstanding beginning of year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">-</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Granted</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">356,000</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Outstanding and exercisable, end of year</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">356,000</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">3.00</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2021 gryn Weighted Average Exercise Price Outstanding Beginning Of Year
WeightedAverageExercisePriceOutstandingBeginningOfYear
0
CY2021 gryn Number Of Warrants Granted
NumberOfWarrantsGranted
356000 shares
CY2021 gryn Weighted Average Exercise Price Granted
WeightedAverageExercisePriceGranted
3.00
CY2021 gryn Number Of Warrants Outstanding And Exercisable End Of Year
NumberOfWarrantsOutstandingAndExercisableEndOfYear
356000 shares
CY2021 gryn Weighted Average Exercise Price Outstanding And Exercisable End Of Year
WeightedAverageExercisePriceOutstandingAndExercisableEndOfYear
3.00
CY2021Q4 gryn Gain On Forgiveness Of Payabletextblock
GainOnForgivenessOfPayabletextblock
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>11. Gain on Forgiveness of payable</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>  </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">For the three months ended October 31,2021, the company recognized a gain of $180,000 related to a forgiveness of payables from a company that was contracted to perform consulting services related to the accounting and preparation of the company’s quarterly financials.  The company received written from the consultant notifying the company of the forgiveness.</p>
CY2021Q4 gryn Gain On Forgiveness Of Payable
GainOnForgivenessOfPayable
180000 USD

Files In Submission

Name View Source Status
0001477932-22-000262-index-headers.html Edgar Link pending
0001477932-22-000262-index.html Edgar Link pending
0001477932-22-000262.txt Edgar Link pending
0001477932-22-000262-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gryn-20211031.xsd Edgar Link pending
gryn-20211031_cal.xml Edgar Link unprocessable
gryn-20211031_def.xml Edgar Link unprocessable
gryn-20211031_lab.xml Edgar Link unprocessable
gryn-20211031_pre.xml Edgar Link unprocessable
gryn_10q.htm Edgar Link pending
gryn_10q_htm.xml Edgar Link completed
gryn_ex311.htm Edgar Link pending
gryn_ex312.htm Edgar Link pending
gryn_ex321.htm Edgar Link pending
gryn_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending